Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach.
- Resource Type
- Article
- Source
- Applied Health Economics & Health Policy; Nov2022, Vol. 20 Issue 6, p867-880, 14p
- Subject
- Language
- ISSN
- 11755652